ArticleExperimental and therapeutic medicine2012

Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma.

Kouichi Haraguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.